Study on the platelet factor and beta-thromboglobulin in the patients with ischemic heart disease
- PMID: 15759368
- PMCID: PMC4534903
- DOI: 10.3904/kjim.1986.1.1.1
Study on the platelet factor and beta-thromboglobulin in the patients with ischemic heart disease
Abstract
The platelet factor 4 (PF4) and β-thromboglobulin (β-TG) were measured to evaluate the platelet activation in vivo in patients with ischemic heart disease. The results are summarized as follows:
In patients with acute myocardial infarction, the PF4 and the β-TG levels were significantly higher compared to those of normal controls (P<0.005).
In patients with angina pectoris, the PF4 and the β-TG levels were not signivicantly different from those of normal controls.
A pattern of decline in the PF4 and the β-TG level was shown in patients with acute myocardial infarction by day 10. In conclusion, the measurement of PF4 and β-TG is a useful method to detect the platect activation in vivo in the patients with ischemic heart disease.
Figures




Similar articles
-
[Beta-thromboglobulin (beta-TG)].Nihon Rinsho. 2004 Dec;62 Suppl 12:734-7. Nihon Rinsho. 2004. PMID: 15658437 Review. Japanese. No abstract available.
-
Platelet activation markers in long-term follow-up of young subjects with acute myocardial infarction.Clin Hemorheol Microcirc. 2006;35(4):527-8. Clin Hemorheol Microcirc. 2006. PMID: 17148852 No abstract available.
-
Beta-thromboglobulin (beta tg) and platelet factor 4 (PF4) in patients with myeloproliferative diseases.Thromb Haemost. 1994 Sep;72(3):484-6. Thromb Haemost. 1994. PMID: 7710537 No abstract available.
-
Beta-thromboglobulin and platelet factor 4 in juvenile myocardial infarction.Clin Appl Thromb Hemost. 2007 Jan;13(1):108-9. doi: 10.1177/1076029606296424. Clin Appl Thromb Hemost. 2007. PMID: 17164501 No abstract available.
-
[Platelet factor 4 and beta-thromboglobulin].Rinsho Byori. 1987 Jun;Spec No 71:192-7. Rinsho Byori. 1987. PMID: 2957528 Review. Japanese. No abstract available.
Cited by
-
Biomarkers of coagulation, endothelial, platelet function, and fibrinolysis in patients with COVID-19: a prospective study.Sci Rep. 2024 Jan 23;14(1):2011. doi: 10.1038/s41598-024-51908-9. Sci Rep. 2024. PMID: 38263377 Free PMC article.
-
Off-Target Effects of Antidepressants on Vascular Function and Structure.Biomedicines. 2021 Dec 28;10(1):56. doi: 10.3390/biomedicines10010056. Biomedicines. 2021. PMID: 35052735 Free PMC article. Review.
-
Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease.Front Cardiovasc Med. 2021 Jun 21;8:684920. doi: 10.3389/fcvm.2021.684920. eCollection 2021. Front Cardiovasc Med. 2021. PMID: 34235190 Free PMC article. Review.
References
-
- Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med. 1976;295:369. - PubMed
-
- Wissler RW, Vesselinovitch D. Atherosclerosis-Relationship to coronary blood flow: symposium on the physiology and pathology of the coronary circulation and coronary heart disease. Am J Cardiol. 1983;52:2A. - PubMed
-
- Schafer AI, Handin RI. The role of platelets in thrombotic and vascular disease. Progress in Cardiovascular disease. 1979;XXII:31. - PubMed
-
- Harvey JW. Platelet physiology and abnormalities of platelet function. N Engl J Med. 1975;293(531) - PubMed
-
- Levine SP, Wohl H. Human platelet factor 4 (PF4) purification and characterization by affinity chromatography. Journal of Biological Chemistry. 1976;251:324. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous